Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2021; 46(4): 799-802


Comparison of eosinophil derived neurotoxin, immunoglobulin E and absolute eosinophil count in severe persistent asthmatic and non-asthmatic adults

Haji Muahammad Rashid, Sumbla Ghaznavi, Nadia Awan.




Abstract

Objective: To compare Absolute eosinophil count (AEC), IgE and Eosinophil derived neurotoxin (EDN) between severe persistent asthmatic and non-asthmatic adults and to find the correlation of EDN with AEC and Forced Expiratory Volume (FEV) in severe persistent asthmatic patients.
Methodology: This cross sectional study was carried out at the Department of Chemical Pathology, University of Health Sciences Lahore, Pakistan. Pre diagnosed 32 severe persistent asthmatic patients and 32 ages and gender matched non-asthmatic adults were enrolled in the study. Their lung function data and blood samples for the assessment of AEC, IgE and EDN were collected. Pair wise comparisons between two groups were performed by Mann-Whitney U test.
Results: AEC in severe persistent asthmatic patients (546±411 /ul) was significantly higher than non-asthmatic adults (125±64/ul). Serum IgE (845.3±334.3 IU/L) and EDN (34881±12321ng/ml) were also high in severe persistent asthmatic patients than non-asthmatic adults (p

Key words: Asthma, spirometry, eosinophil, eosinophil derived neurotoxin, immunoglobulin E, severe persistent asthma.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.